Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Multiple Sclerosis
Multiple Sclerosis News
Europe Reaffirms Gadolinium Restriction in ScansAfter reexamination, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee has reaffirmed that there is evidence that the contrast agent is deposited in the brain.
Medscape Medical News, July 7, 2017
AlertEMA Restricts Use of Daclizumab (Zinbryta) in MSThe EMA provisionally restricts use of daclizumab to patients with highly active relapsing MS who fail other treatments and advises against its use in the setting of liver disease.
Gadolinium Contrast Agents and Brain Safety: Signal vs NoiseGadolinium deposits in brain tissue of patients who had multiple gadolinium-enhanced MRIs prompted an FDA review, which concluded that no restrictions were necessary. Practitioners remain cautious.
